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ABSTRACT: 
 
The aqueous extract was found to be more effective on the surfactant system of lung against ova 
albumin and aluminium hydroxide induced lung damage in albino wistar rats.  The rats were 
divided into 3groups of four animals each, namely group I, II and III which served as control, 
toxic and post treatment groups respectively.  Our results showed increased Lung Body-Weight 
Index (LBI) and decreased lung lipid content in the toxic group of animals.  But the levels of 
lipid content and Lung Body-Weight Index were restored in post-treated group of animals, which 
might be due to the protective activity of “Pentapala-04”. 
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INTRODUCTION 
 
The lung is an active metabolic organ
1, 
which is lined with high surface-active 
materials like lipids mainly phospholipids 
and some specific proteins
2.  Lamellar 
bodies are lipid-rich organelles in the lung 
and contain a variety of lysomal hydrolases
3, 
and such enzymes are also found in lung 
lavage.  The lysosomal character of these 
organelles may play a degradative role
4,5.  
Lipids mediate the stimulatory effect, and 
increase in molecular weight of the cytosolic 
enzyme in liver form 200,000 to a mean of 
1.3 x 10
6.  Fatty acids were reported to 
stimulate phosphatidylcholine synthesis and 
promote translocation of cytidyl transferases 
form cytosol to microsomes
7. 
 
Medicinal plants contain a wide range of 
chemical compounds that could serve as 
“Leads” for the development of novel anti-
asthmatic agents.  A vast number of 
medicinal plants have been used 
traditionally in the Ayurvedic system of 
medicine for the management of asthma and 
have been scientifically proven to have anti-
asthmatic properties.  Hence, the present 
study involves the use of a herbal 
formulation “Pentapala-04” which includes 
the extract of five medicinal plants viz., 
Adhatoda vasica: Nees., Ocimum sanctum; 
Linn., Coleus aromaticus; Benth., 
Glycyrrhiza glabra; Linn., and Alpinia 
galangal; Sw., against ova albumin and 
aluminium hydroxide induced lung damage 
in rats. 
 
MATERIALS AND METHODS 
PREPARATION OF EXTRACTS: 
 
A polyherbal drug “Pentapala-04” consists 
of five different plants viz, Adhatoda vasica; 
Nees. Ocimum sanctum; Linn.  Coleus 
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aromaticus; Benth.  Glycyrrhiza; Linn. and 
Alpinia galanga; Sw.  The young and fresh 
leaves and roots were collected from palani 
Hills, Coimbatore (TamilNadu, India).   
Aqueous extract (6.25%) was prepared 
under boiling water (<100
oC) at normal 
pressure
8.  The aqueous extract was 
subjected to studies in laboratory animals. 
 
EXPERIMENTAL DESIGN AND 
ANIMAL SENSITIZATION: 
 
Albino wistar rats (150-200g) were bred in 
the central animal house, P.S.G. Institute of 
Medical College, Coimbatore.  The animals 
were fed with a pellet diet [Hindustan Lever 
Ltd; Mumbai] and water ad libitum. The 
animals were maintained in their respective 
controlled light and temperature conditions 
for 30 days. 
 
Animals were divided into three groups of 
four animals each Group I, II and III served 
as control, toxic and post treated groups 
respectively.  Group II and Group III 
animals were sensitized by subcutaneous 
injection of 1 ml saline containing 1 mg of 
ova albumin and 200 mg of aluminium 
hyfdroxide
9.  Group III rats were post 
treated with “Pentapala 04” (0.2ml/kg body 
wt) extract, twice a day form 2
nd day to 9
th 
day after sensitization. 
 
After 9
th day of treatment, the whole rats 
were fasted overnight and sacrificed by 
cervical decapitation.  Lungs were excised 
immediately, and weight (wet and dry) was 
determined, then biochemical assays were 
carried out. 
 
LUNG BODY- WEIGHT INDEX (LABI) 
10. 
 
The lungs were removed, freed from 
adhering tissues, blood and weighed.  The 
LBI was calculated by the formula  
   
Lung weight 
LBI = ________________________x100 
                       Body weight 
 
BIOCHEMICAL ANALYSIS OF LUNG: 
 
From the lung tissue, we extracted lipids by 
the method as described by Folch et al., 
(1957)
11.  these lipids were used to assay the 
triglycerides, free cholesterol, total 
cholesterol, phospholipids and fatty acids 
according to method described by Rice 
(1970)
12, Sperry and Webb (1950)
13, 
Parckhand Jung (1970)
14 Rouser et al., 
(1970)
15, and Horn (1981)
16 respectively. 
 
RESULT AND DISCUSSION 
 
Results are expressed as mean ± SEM.   
Statistical significance between control, 
toxic, and post treated groups were analyzed 
using student’s test. 
 
Table 1 shows that there is significant 
(P<0.001) increase of LBI in the toxigen as 
compared to the control group.  Similar 
results have been reported by Abraham et 
al., (1992)
17.  LBI might be increased due to 
pulmonary edema and haemorrhage
18.  After 
the treatment with “Pentapala-04” there was 
a significant (P<0.001) decrease in LBI as 
compared to toxic group.  Our result is in 
accordance with sharma et al., (1987)
19. 
 
Effect of “Pentapala-04” on the lung lipids 
is depicted in the table II. In the toxic group, 
the lipid profile like cholestrol, 
phospholipids, free fatty acid, and 
triglycerides were reduced significantly 
(P<0.001) when compared to control group.  
While in treated rats, there are significant 
(P<0.0014) increased levels of above said 
lipid profiles as compared to toxic rats. 
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Asthma is characterized by airway hyper-
responsiveness, which is an exaggerated 
airway narrowing in response to many 
stimuli.  Asthma has become the most 
common chronic disease in the world and 
epidemiological studies suggest that it’s 
prevalence, severity, and mortality rate are 
rising.  The commonly used anti-asthmatic 
drugs like bronchodilators and â agonists 
may rapidly relieve asthmatic symptoms but 
they may not control the underlying 
inflammation.  Since asthma is a chronic 
inflammatory condition, it may be more 
logical to adopt, anti –inflammatory 
treatment to control the inflammation, Anti-
inflammatory treatment includes the use of 
corticosteroids which are very effective in 
the treatment of asthma, but corticosteroids 
are costly and if given systemically, have 
severe adverse effects. 
 
Thus our studies provide experimental 
evidence for the protection of surfactant 
systems of lung by “Pentapala-04” without 
any side effects. 
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Table I 
Effect of “Pentapala – 04” on the Lung Body – Weight index in experimental and control rats. 
  Control 
(Group I) 
Toxic 
(Group II) 
Treated 
(Group III) 
Wet Weight lung(g)  1.71 ± 0.14  2.12±0.09a**  1.55±0.06b*** 
Dry Weight lung(g)  0.16±0.02  0.28±0.02a***  0.15±0.012b*** 
LBI (%)  0.95±0.02  1.27±0.06a***  0.93±0.012b*** 
 Each value represent the Mean ± SEM. (n=4). 
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Statistical Comparison 
 
a-Group II Compared with Group I 
b-Group III Compared with Group II 
**Significant (P<0.01), *** Highly significant (P<0.001) 
Units=mg/g.tissue 
 
Table II 
Effect of “Pentapala-04” on the Lipid profile of the lung tissue in experimental and control rats. 
 
 
  
  Control 
(Group I) 
Toxic 
(Group II) 
Treated 
(Group III) 
Total Cholesterol  3.21 ±0.37  2.54±0.06
a** 3.11±0.13
b*** 
Free Cholesterol  1.20±0.08  0.67±0.12
a*** 1.00±0.06
b*** 
Phospholipids 14.02±0.51  12.55±0.38
a*** 13.78±0.36
b*** 
Free fatty acids  6.93±0.42  3.90±0.68
a*** 5.86±0.14
b*** 
Triglycerides 3.78±0.12  2.47±0.11
a*** 3.57±0.10
b*** 
 
Each value represent the Mean±SEM.n=4). 
Statistical Comparison 
 
a-Group II Compared with Group I 
B-Group III Compared with Group11 
**Significant (P<0.01), ***Highly significant (P<0.001) 
units=mg/g. tissue  
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